10-Q: Vireo Growth Inc. Reports Q1 2025 Financial Results, Revenue Up Slightly Amid Strategic Shifts
Quarterly Report
Vireo Growth Inc. announces a marginal increase in revenue for Q1 2025, highlighting strategic realignments and merger agreements.
Summary
- Vireo Growth Inc. reported a revenue increase of 2% for the three months ended March 31, 2025, reaching $24,540,641 compared to $24,087,315 in the same period of 2024.
- The increase is primarily attributed to higher revenue from Maryland's wholesale business, offsetting a decline in New York revenues.
- Retail revenue decreased slightly by 2% to $19,233,641, while wholesale revenue increased by 18% to $5,307,000.
- The company's gross profit remained relatively stable at $12,412,312, representing a gross margin of 51%.
- Operating income before other income (expense) and income taxes decreased to $1,975,689 from $4,759,444 in the prior year.
- Net loss and comprehensive loss was $(6,508,790) compared to $(6,711,460) for the three months ended March 31, 2024.
- The company is in the midst of a transformation to being significantly more customer-centric across its operations.
- The company is pursuing merger agreements with Deep Roots, Proper, and Wholesome, with none of the mergers contingent on the completion of the others.
- As of March 31, 2025, the company had $86,260,997 in cash.
Sentiment
Score: 5
Explanation: The document presents a mixed sentiment. While revenue increased slightly, profitability metrics declined, and the company is undergoing strategic shifts and divestitures. The ongoing litigation and regulatory uncertainties add to the neutral outlook.
Positives
- Revenue increased by 2% compared to the same period last year.
- Wholesale revenue increased by 18% due to increased revenue contributions from the Maryland business.
- The company received $972,888 related to the CARES Employee Retention credit.
- The company is actively managing its capital structure, including extending the maturity date on its Credit Facility loans to January 29, 2027.
- The company is pursuing strategic mergers with Deep Roots, Proper, and Wholesome to expand its market presence.
Negatives
- Retail revenue decreased slightly by 2% compared to the same period last year.
- Operating income decreased from $4,759,444 to $1,975,689.
- The company reported a net loss of $(6,508,790) for the quarter.
- Total expenses increased by $2,951,640 compared to the same period last year.
- The company is divesting assets in New York, Nevada, and Massachusetts, indicating potential challenges in those markets.
Risks
- The cannabis industry faces regulatory uncertainty at the federal level in the U.S.
- The company operates in a highly competitive market with potential for price compression.
- The outcome of the litigation with Verano is uncertain, with potential for significant damages.
- The company's access to financing is always uncertain.
- The company carries variable interest-bearing debt subject to fluctuations in the United States Prime rate.
Future Outlook
The company expects future operations to benefit from increased revenue growth reflective of higher demand, increased product output and new product development, but anticipates gradual price compression as markets mature.
Management Comments
- The Company is evolving with the industry and is in the midst of a transformation to being significantly more customer-centric across its operations.
Industry Context
The company operates in the cannabis industry, which is subject to evolving state regulations and federal prohibition, creating both opportunities and challenges.
Comparison to Industry Standards
- The document does not provide enough information to make a detailed comparison to industry standards.
- Comparable companies in the cannabis industry include Curaleaf, Trulieve, and Green Thumb Industries.
- These companies often report metrics such as revenue growth, gross margin, and EBITDA, which can be used to benchmark Vireo Growth's performance.
- However, without specific data on these metrics for comparable companies, a precise comparison is not possible.
Legal Proceedings
- Vireo Growth is involved in a legal proceeding against Verano Holdings Corp. related to the termination of an arrangement agreement.
- The company is seeking substantial damages, specifically US $860.9 million, as well as other costs and legal fees, based on Veranos breach of contract and of its duty of good faith and honest performance.
- The Preliminary Suitability Application is currently set for hearing on June 15 and 16, 2025.
Related Party Transactions
- Our Chief Executive Officer, John Mazarakis, serves as a partner of Chicago Atlantic Group, LP, which is an affiliate of the Agent, our senior secured lender under the Credit Facility.
- Given his ownership interest in the Agent and its affiliates, Mr. Mazarakis has an approximate 29% interest in the Companys transactions with the Agent.
Stakeholder Impact
- Shareholders are impacted by the company's financial performance and strategic decisions.
- Employees are impacted by the company's operational changes and potential divestitures.
- Customers are impacted by the availability and quality of cannabis products.
- Suppliers and creditors are impacted by the company's financial stability and ability to meet its obligations.
Next Steps
- The company will continue to pursue its merger agreements with Deep Roots, Proper, and Wholesome.
- The company will continue to manage its liquidity and capital resources.
- The company will continue to monitor and manage the litigation with Verano.
- The company will continue to divest assets in New York, Nevada, and Massachusetts.
Key Dates
| Date | Description |
|---|---|
| November 23, 2004 | Vireo Growth Inc. was incorporated under the Alberta Business Corporations Act. |
| October 21, 2022 | Vireo Growth commenced an action in the Supreme Court of British Columbia against Verano Holdings Corp. |
| January 31, 2022 | Vireo Growth entered into the Arrangement Agreement with Verano. |
| February 22, 2024 | The Company executed a lease for cannabis cultivation and manufacturing facilities. |
| May 2, 2024 | The Company filed a Summary Trial Application with the Supreme Court of British Columbia seeking summary determination in the Verano litigation. |
| July 8, 2024 | The Company changed its name to Vireo Growth Inc., its ticker symbol on the CSE to VREO and its ticker symbol on the OTCQX to VREOF. |
| June 19, 2024 | Verano filed a Notice of Application seeking orders dismissing the Summary Trial Application. |
| July 31, 2024 | Holders voluntarily converted convertible notes issued in 2023 into 73,016,061 Subordinate Voting Shares of the Company. |
| July 31, 2024 | The Company executed a ninth amendment to the Companys Credit Facility. |
| November 1, 2024 | The Company entered into a Joinder and Tenth Amendment to Credit Agreement. |
| December 18, 2024 | Vireo Growth Inc. entered into Merger Agreements with respect to a business combination with each of Deep Roots Holdings, Inc., Proper Holdings Management, Inc. and NGH Investments, Inc., and WholesomeCo, Inc. |
| March 4, 2025 | Filing of Annual Report on Form 10-K for the fiscal year ended December 31, 2024. |
| March 21, 2025 | A Schedule 14C information statement was prepared by the Company and filed with the SEC and mailed to the stockholders of the Company relating to stockholder approval of the issuance of the Companys subordinate voting shares in the Mergers. |
| March 31, 2025 | End of the quarterly period. |
| May 7, 2025 | As of this date, the registrant had the following number of shares of each of its classes of registered securities outstanding: Subordinate Voting Shares 339,475,288; Multiple Voting Shares 278,170; and Super Voting Shares 0. |
| June 15 and 16, 2025 | The Preliminary Suitability Application is currently set for hearing. |
| July 31, 2025 | Adjusts and extends the deadline with respect to the Companys ongoing disposition of its New York operations. |
| December 31, 2026 | Former stockholders of each of Deep Roots, Proper and Wholesome may qualify for earnout payments. |
Keywords
cannabis, revenue, merger, wholesale, retail, EBITDA, litigation, financial results, Vireo Growth, divestiture
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.